Topics

NICE greenlights Consilient Health's Elmiron for bladder pain syndrome

07:09 EST 14 Nov 2019 | Pharmafile

NICE has chosen to recommend Consilient Health’s Elmiron(pentosan polysulfate sodium) for the treatment of bladder pain syndrome (BPS), it has emerged, for patients whose condition has not responded to oral treatments and are not offered the drug in combination with bladder instillations.

The decision was reached as the two parties agreed to a patient access scheme to make the drug available to NHS patients.

read more

Original Article: NICE greenlights Consilient Health's Elmiron for bladder pain syndrome

NEXT ARTICLE

More From BioPortfolio on "NICE greenlights Consilient Health's Elmiron for bladder pain syndrome"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Bladder Cancer
Non-invasive bladder cancer is a cancer that is only in the inner lining of the bladder. Invasive bladder cancer is cancer that has spread into the deeper walls of the bladder. When the cancer has spread outside the bladder to other parts of the body, th...